Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$7.23 USD
+0.13 (1.83%)
Updated Jul 19, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Balance Sheet
Fiscal Year End for Mesoblast Limited falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 71 | 60 | 137 | 129 |
Receivables | NA | 7 | 4 | 5 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 3 | 5 | 7 | 6 |
Total Current Assets | NA | 82 | 70 | 148 | 137 |
Net Property & Equipment | NA | 1 | 2 | 3 | 2 |
Investments & Advances | NA | 2 | 2 | 2 | 2 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 577 | 579 | 581 | 582 |
Deposits & Other Assets | NA | 2 | 2 | 2 | 3 |
Total Assets | NA | 669 | 662 | 745 | 734 |
Liabilities & Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 20 | 23 | 20 | 25 |
Current Portion Long-Term Debt | NA | 6 | 5 | 53 | 32 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 12 | 20 | 19 | 29 |
Total Current Liabilities | NA | 42 | 51 | 94 | 90 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 103 | 92 | 41 | 57 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 19 | 15 | 20 | 30 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 168 | 165 | 163 | 184 |
Shareholders Equity | 6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1,249 | 1,165 | 1,163 | 1,051 |
Capital Surplus | NA | 0 | 0 | 0 | 0 |
Retained Earnings | NA | -821 | -739 | -648 | -549 |
Other Equity | NA | 74 | 71 | 66 | 47 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 502 | 497 | 581 | 549 |
Total Liabilities & Shareholder's Equity | NA | 669 | 662 | 745 | 734 |
Total Common Equity | 0 | 502 | 497 | 581 | 549 |
Shares Outstanding | 114.10 | 81.40 | 65.00 | 64.80 | 58.40 |
Book Value Per Share | 0.00 | 6.17 | 7.65 | 8.97 | 9.41 |
Fiscal Year End for Mesoblast Limited falls in the month of June.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,921 | -99,999 | 71 |
Receivables | NA | NA | 4 | NA | 7 |
Notes Receivable | NA | NA | NA | NA | 0 |
Inventories | NA | NA | NA | NA | 0 |
Other Current Assets | NA | NA | 4 | NA | 3 |
Total Current Assets | NA | NA | 85 | NA | 82 |
Net Property & Equipment | NA | NA | 1 | NA | 1 |
Investments & Advances | NA | NA | 1 | NA | 2 |
Other Non-Current Assets | NA | NA | NA | NA | 0 |
Deferred Charges | NA | NA | NA | NA | 0 |
Intangibles | NA | NA | 577 | NA | 577 |
Deposits & Other Assets | NA | NA | 2 | NA | 2 |
Total Assets | NA | NA | 670 | NA | 669 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | NA | 0 |
Accounts Payable | NA | NA | 11 | NA | 20 |
Current Portion Long-Term Debt | NA | NA | 9 | NA | 6 |
Current Portion Capital Leases | NA | NA | NA | NA | 0 |
Accrued Expenses | NA | NA | NA | NA | 0 |
Income Taxes Payable | NA | NA | NA | NA | 0 |
Other Current Liabilities | NA | NA | 9 | NA | 12 |
Total Current Liabilities | NA | NA | 31 | NA | 42 |
Mortgages | NA | NA | NA | NA | 0 |
Deferred Taxes/Income | NA | NA | NA | NA | 0 |
Convertible Debt | NA | NA | NA | NA | 0 |
Long-Term Debt | NA | NA | 107 | NA | 103 |
Non-Current Capital Leases | NA | NA | NA | NA | 0 |
Other Non-Current Liabilities | NA | 20 | NA | 19 | |
Minority Interest (Liabilities) | NA | NA | NA | NA | 0 |
Total Liabilities | NA | NA | 162 | NA | 168 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | NA | 0 |
Common Stock (Par) | NA | NA | 1,286 | NA | 1,249 |
Capital Surplus | NA | NA | NA | NA | 0 |
Retained Earnings | NA | NA | -853 | NA | -821 |
Other Equity | NA | NA | 76 | NA | 74 |
Treasury Stock | NA | NA | NA | NA | 0 |
Total Shareholder's Equity | NA | NA | 509 | NA | 502 |
Total Liabilities & Shareholder's Equity | NA | NA | 670 | NA | 669 |
Total Common Equity | 0 | 0 | 100,508 | 0 | 502 |
Shares Outstanding | 114.10 | 114.00 | 101.50 | 81.40 | 81.40 |
Book Value Per Share | 0.00 | 0.00 | 990.22 | 0.00 | 6.17 |